Hap Trading, LLC Neurocrine Biosciences Inc Call Options Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	BUY	$114.58 - $153.15 $1.57 Million - $2.1 Million	13,700 New	13,700 $12.6 Million
Q3 2020 Nov 13, 2020	SELL	$96.16 - $135.15 $5.64 Million - $7.93 Million	-58,700 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$85.09 - $130.36 $4.99 Million - $7.65 Million	58,700 New	58,700 $1.84 Million
Q1 2019 May 10, 2019	SELL	$69.31 - $91.53 $3.87 Million - $5.12 Million	-55,900 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$68.32 - $124.36 $3.82 Million - $6.95 Million	55,900 New	55,900 $138,000

627

94.2M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.